|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Epidemiologic Notes and Reports Arsenic Contamination in an Abandoned Building -- OhioInvestigators from the National Institute for Occupational Safety and Health (NIOSH) recently re-evaluated residual arsenic contamination in an abandoned building in Norwood, Ohio (1). At the request of the local health department, NIOSH had evaluated the same building in 1974 and found it highly contaminated by an arsenic trioxide rodenticide that had been mixed and packaged in the building nearly 40 years earlier. On October 22, 1981, NIOSH investigators collected 14 dust samples from the floor, walls, and ceiling beams throughout the building and analyzed them for arsenic content by atomic absorption spectrophotometry. Six samples from the floor contained from 3% to 41% arsenic by weight (30,000 to 410,000 parts per million). Five wipe samples from wall surfaces contained from 0.5 to 310 ug of arsenic per square inch of surface area, and three wipe samples from ceiling-beam surfaces contained from 130 to 2100 ug of arsenic per square inch. (Normal levels are 0.5 ug.) The highest arsenic concentrations were found in the northeast quadrant of the building--the area where the mixing and packaging had reportedly been done. On February 2, 1982, NIOSH presented the results to the Norwood City Health Department with recommendations for decontamination and guidelines for protection of workers during decontamination. Reported by Hazard Evaluations and Technical Assistance Br, Div of Surveillance, Hazard Evaluations, and Field Studies, NIOSH, CDC. Editorial NoteEditorial Note: Although most occupational exposure to arsenic is by inhalation, it can also occur through ingestion or skin absorption. Once absorbed, arsenic is widely distributed throughout the body tissues, including the liver, other abdominal viscera, bone, and skin. Chronic exposure to arsenic, particularly to the trivalent form, manifests itself by: weakness, weight loss, nausea, diarrhea, constipation, skin disorders, hair loss, abdominal pain, pleuritis, and peripheral neuritis. Numerous studies indicate that arsenic compounds, including arsenic trioxide, can cause cancer of the skin, liver, lung, and possibly the lymphatic system (2,3). Arsenic rodenticides are generally effective against Norway and roof rats, but not against house mice. This lack of broad-spectrum effectiveness, coupled with the inherent toxicity of arsenic compounds to man, has led to a decline in the use of arsenic as a rodenticide (4). In August 1967, the United States Environmental Protection Agency (EPA) banned arsenic trioxide for home use in concentrations 1.5%. To protect workers removing arsenic from a contaminated building, NIOSH recommends the following procedures:
References
Disclaimer All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 08/05/98 |
|||||||||
This page last reviewed 5/2/01
|